Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Craft a robust retirement readiness plan at 55 by including these essential elements. Ensure you’re prepared for the lifestyle you desire.
21,951 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Hong Kong lays out plans to connect a new digital bond platform with regional tokenization hubs, moving from pilots t...
IonQ stunned traders with a sharp rally after reporting stronger-than-expected 2025 results and a robust 2026 revenue...
This guide breaks down ameresco (amrc) 2025 earnings, what drives results, and how investors can position themselves ...
Apple’s latest strategy signals a shift from pure premium to share growth. This article explores how pricing, service...
Two popular dividend payers, AGNC and Realty Income, appeal to income investors for different reasons. This guide bre...
A high-profile insider sale at Urban Outfitters has investors weighing risk and opportunity. Learn how to interpret t...
Federal OSHA has opened a federal review of Nevada’s workplace safety agency after three willful citations against El...
Kraft Heinz pauses its planned breakup after a string of profit slips and a Berkshire Hathaway stake-shift. The move ...
Tilray Brands is expanding beyond its cannabis roots into beverages and other segments. This article examines whether...
New York's transit agency filed a federal lawsuit against the federal government after nearly $60 million in subway f...
Rivian and NIO shares fell about 7% amid renewed skepticism about rapid EV growth. Investors are demanding clear prof...